Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Raz

Showing results (171-180 of 316) with videos related to

Pageof 32
Sort By:
Advances in Prostaglandin and Thromboxane Research|January 1, 1978
Lipases and prostaglandin biosynthesisP C Isakson, A Raz, W Hsueh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1977
Application of imidazole as a selective inhibitor thromboxane synthetase in human plateletsP Needleman, A Raz, J A Ferrendelli, et al.
Biochemical and Biophysical Research Communications|December 5, 1995
Galectin-3 is a nuclear matrix protein which binds RNAL Wang, H Inohara, K J Pienta, et al.
Analytical Biochemistry|March 9, 2000
Electrospray/tandem mass spectrometry for quantitative analysis of lipid remodeling in essential fatty acid deficient miceK Duffin, M Obukowicz, A Raz, et al.
The American Journal of Pathology|June 1, 1997
Improved prognosis assessment for patients with bladder carcinomaT Otto, A Bex, U Schmidt, et al.
Biochimica Et Biophysica Acta|September 22, 1978
A differential interaction of daunomycin, adriamycin and their derivatives with human erythrocytes and phospholipid bilayersR Goldman, T Facchinetti, D Bach, et al.
Biochemical Pharmacology|March 10, 2001
Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivoY Eli, F Przedecki, G Levin, et al.
International Journal of Oncology|May 10, 2011
Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-lineP Nangiamakker, E Thompson, C Hogan, et al.
Cancer Research|July 1, 1996
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptideH Watanabe, K Takehana, M Date, et al.
Nature|December 13, 1984
Participation of p53 cellular tumour antigen in transformation of normal embryonic cellsD Eliyahu, A Raz, P Gruss, et al.
Pageof 32

Showing results (171-180 of 316) with videos related to

Sort By:
Pageof 32
Advances in Prostaglandin and Thromboxane Research|January 1, 1978
Lipases and prostaglandin biosynthesisP C Isakson, A Raz, W Hsueh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 1, 1977
Application of imidazole as a selective inhibitor thromboxane synthetase in human plateletsP Needleman, A Raz, J A Ferrendelli, et al.
Biochemical and Biophysical Research Communications|December 5, 1995
Galectin-3 is a nuclear matrix protein which binds RNAL Wang, H Inohara, K J Pienta, et al.
Analytical Biochemistry|March 9, 2000
Electrospray/tandem mass spectrometry for quantitative analysis of lipid remodeling in essential fatty acid deficient miceK Duffin, M Obukowicz, A Raz, et al.
The American Journal of Pathology|June 1, 1997
Improved prognosis assessment for patients with bladder carcinomaT Otto, A Bex, U Schmidt, et al.
Biochimica Et Biophysica Acta|September 22, 1978
A differential interaction of daunomycin, adriamycin and their derivatives with human erythrocytes and phospholipid bilayersR Goldman, T Facchinetti, D Bach, et al.
Biochemical Pharmacology|March 10, 2001
Comparative effects of indomethacin on cell proliferation and cell cycle progression in tumor cells grown in vitro and in vivoY Eli, F Przedecki, G Levin, et al.
International Journal of Oncology|May 10, 2011
Induction of tumorigenicity by galectin-3 in a nontumorigenic human breast-carcinoma cell-lineP Nangiamakker, E Thompson, C Hogan, et al.
Cancer Research|July 1, 1996
Tumor cell autocrine motility factor is the neuroleukin/phosphohexose isomerase polypeptideH Watanabe, K Takehana, M Date, et al.
Nature|December 13, 1984
Participation of p53 cellular tumour antigen in transformation of normal embryonic cellsD Eliyahu, A Raz, P Gruss, et al.
Pageof 32